The polysaccharide capsule of the fungus Cryptococcus neoformans is its main virulence factor. In this study, we determined the effects of mannitol and glucose on the capsule and exopolysaccharide production. Growth in mannitol significantly increased capsular volume compared with cultivation in glucose. However, cells grown in glucose concentrations higher than 62.5 mM produced more exopolysaccharide than cells grown in mannitol. The fibre lengths and glycosyl composition of capsular polysaccharide from yeast grown in mannitol was structurally different from that of yeast grown in glucose. Furthermore, mannitol treatment of mice infected intratracheally with C. neoformans resulted in fungal cells with significantly larger capsules and the mice had reduced fungal dissemination to the brain. Our results demonstrate the capacity of carbohydrate source and concentration to modify the expression of a major virulence factor of C. neoformans. These findings may impact the clinical management of cryptococcosis. Introductionc mi_1430 740..753
The polysaccharide capsule of the fungus Cryptococcus neoformans is its main virulence factor. In this study, we determined the effects of mannitol and glucose on the capsule and exopolysaccharide production. Growth in mannitol significantly increased capsular volume compared with cultivation in glucose. However, cells grown in glucose concentrations higher than 62.5 mM produced more exopolysaccharide than cells grown in mannitol. The fibre lengths and glycosyl composition of capsular polysaccharide from yeast grown in mannitol was structurally different from that of yeast grown in glucose. Furthermore, mannitol treatment of mice infected intratracheally with C. neoformans resulted in fungal cells with significantly larger capsules and the mice had reduced fungal dissemination to the brain. Our results demonstrate the capacity of carbohydrate source and concentration to modify the expression of a major virulence factor of C. neoformans. These findings may impact the clinical management of cryptococcosis.
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Cryptococcosis is an opportunistic infection caused by the encapsulated yeast Cryptococcus neoformans (Cn) . Cn has a worldwide distribution (Muller, 1994; Jain et al., 2005) and is a major fungal pathogen in immunocompromized hosts, especially in individuals with HIV infection (Chayakulkeeree and Perfect, 2006; Park et al., 2009 ). The fungus expresses a variety of well-defined and characterized virulence factors, including a polysaccharide (PS) capsule, a cell wall-associated laccase and released phospholipases (Kozel, 1995; Hamilton and Goodley, 1996; Buchanan and Murphy, 1998; Perfect et al., 1998; Blackstock et al., 1999; Mcclelland et al., 2005) . The capsule is Cn's most prominent virulence determinant, and acapsular strains are not able to cause disease in immunocompetent hosts (Fromtling et al., 1982; Cross and Bancroft, 1995; Chang et al., 1997) . Furthermore, secreted Cn PS interferes with host responses to infection (Vecchiarelli, 2000) .
The cryptococcal capsule is composed of two major PSs, glucuronoxylomannan (GXM) and galactoxylomannan (GalXM) (Doering, 2000; Mcfadden et al., 2007; Frases et al., 2008; Villena et al., 2008; Yoneda and Doering, 2008) . GXM comprises approximately 90% of the capsule and is formed by a linear (1→3)-a-dmannopyranan main chain bearing b-d-xylopyranosyl (Xyl) in b(1→2) or b(1→4) linkages (Cherniak et al., 1998a) , (1→2)b-d-glucopyranosyluronic acid (GlcA) attached to every third mannose, on average, and 6-Oacetyl substituents (Kozel et al., 1988; Cherniak et al., 1998a, Reese and Doering, 2003; Mcfadden et al., 2006a,b; Nimrichter et al., 2007; Frases et al., 2008) . GalXM is an a(1→6)-galactan containing b(1, 3) oligosaccharyl substitutions at alternate residues of galactose. The oligosaccharide constituents of GalXM are trisaccharide motifs composed of a(1→3)-mannosyl dimers in a(1, 4) linkages to galactosyl units. Each of the trisaccharide components may be substituted with b(1→2)-or b(1→3)-xylosyl residues. In contrast to typical PS production, GXM appears to be synthesized in the cytoplasm and then transported to the cell surface by mechanisms involved in vesicular secretion (Yoneda and Doering, 2006; Rodrigues et al., 2007) . Regarding the capsular structure, O acetylation and/or xylosylation are important for binding of anti-GXM MAbs, complement activation and GXM tissue (Janbon et al., 2001; Kozel et al., 2003) .
Capsular PS thickness is regulated by environmental conditions, and strains with different phenotypes can be biased towards specific organs (Rivera et al., 1998; Zaragoza et al., 2003; Garcia-hermoso et al., 2004; Zaragoza and Casadevall, 2004) . PS synthesis is especially increased by low ferric iron or high CO2 concentrations, and the two effects are additive (Vartivarian et al., 1993; Zaragoza and Casadevall, 2004) . Because of its relevance for Cn survival in different conditions capsular synthesis and assembly has been studied in details. Interestingly, recent physical studies have shown significant differences between capsular PS and exopolysaccharide, suggesting that these two fractions represent distinct biosynthetic products (Frases et al., 2008) . Capsular growth can also be affected by different carbon sources (Onishi and Suzuki, 1968; Golubev and Manukian, 1979; Granger et al., 1985) . Capsular production increases on media with lower amounts of glucose (Okabayashi et al., 2005) ; however, higher levels of exopolysaccharide occur in culture supernatants from high glucose media (Cleare and Casadevall, 1999) . Additionally, mammalian serum or diluted Sabouraud broth efficiently induced capsule growth (Zaragoza and Casadevall, 2004) .
Cryptococcus neoformans is known to produce D-mannitol in vitro (Onishi and Suzuki, 1968) . Glucose concentration of 20% (w/v) induces mannitol production, consisting of 28% molar yield based upon glucose used (Onishi and Suzuki, 1968) . Mannitol is also generated when fructose and mannose are used as carbon sources (Onishi and Suzuki, 1968) . D-mannitol is also produced during cryptococcosis (Wong et al., 1990) . In fact, concentrations of D-mannitol in cerebrospinal fluid (CSF) from rabbits infected with Cn correlated with CSF GXM content and the severity of infection. In humans, mannitol has been detected in 19 of 21 CSF samples evaluated (ranging from 1.5 to 26.2 mg l -1 ; 0.8 mM to 0.14 mM, respectively), but there was no quantitative correlation between the mannitol concentration and the cryptococcal antigen titre (Megson et al., 1996) . D-mannitol is known to scavenge free radicals, reducing the ability of CSF phagocytes to kill Cn yeasts. Niehaus and Flynn (1994) showed that the ability of Cn to catabolize mannitol was constitutively expressed. However, it is not known whether D-mannitol regulates Cn virulence factors or if the carbohydrate impacts pathogenesis (Megson et al., 1996) . In our current work, we sought to evaluate the effect of mannitol on the capsular regulation of Cn. We applied diverse methods, including dynamic light scattering to analyse the dimensions of PS molecules, light microscopy and immunofluorescence, to determine capsule size and GXM properties. We also determined the concentration of GXM in different capsules formed under the different growth conditions and evaluated the importance of capsule thickness induced by mannitol in vivo.
Results

Carbon sources regulate capsular size in a dose-dependent fashion
The growth rate of Cn was similar in all the conditions tested (data not shown). To evaluate the impact of carbon source on capsular growth, Cn yeasts were cultivated in minimal medium containing mannitol or glucose and then stained with Indian ink to assess the capsule volume. Mannitol significantly increased capsule growth compared with glucose over a concentration range of 7.8-500 mM (P < 0.001) (Fig. 1A) . Maximum capsular volume was observed in media with 125 mM of mannitol (18094 Ϯ 501.4 mm 3 ) (Fig. 1B) , followed by media containing 62.5 and 31.25 mM mannitol. Capsular volumes were significantly smaller in the presence of glucose, reaching their maximum size at 62.5 and 15.63 mM (3633 Ϯ 226 mm 3 and 4387 Ϯ 306 mm 3 , respectively) ( Fig. 1B) , followed by concentrations of 250 and 125 mM. In addition, when compared with mannitol, a larger cell body size was observed in cells cultivated in glucose concentrations higher than 62.5 mM (Fig. 1B) . Except for the condition containing mannitol at 125 mM, in which a clearer zone surrounding the cell body was observed, the large capsules in cells cultivated in mannitol were more diffuse, with a higher penetration of India ink particles into regions surrounding the cell body.
Capsular PS and exopolysaccharide production are regulated by the type of carbon source
Changes in the antigenic properties of capsular PSs may occur in vivo (Rivera et al., 1998; Guerrero et al., 2006) . In order to establish the relative amount of reactive epitopes present on the capsule and exopolysaccharide, we performed ELISA assays with monoclonal antibodies to GXM (18B7) . The reactivity of mAb 18B7 to capsular and secreted PSs obtained from yeasts cultivated with different carbon sources was evaluated by ELISA. The greatest capsule volume and highest concentration of PS measured by ELISA was observed with media containing 125 mM of mannitol (P < 0.001, Fig. 1C ). For glucose, maximal capsular epitope production was observed at 250 mM (43.4 vs. 30.7 mg ml -1 of GXM for mannitol, P < 0.001; Fig. 1C ). At carbon source concentrations Ն 250 mM, PS from cells grown in glucose displayed more binding to epitopes recognizable by mAb 18B7 than cells cultured in mannitol (P < 0.001). This effect was reversed for concentrations between 125 and 31.25 mM, where mannitol induced a larger capsule than glucose. When lower carbohydrate concentrations were used, no statistical difference in either capsule size or reactivity was observed. The highest concentrations of exopolysaccharide from Cn grown in glucose were observed at 250 mM (8665 mg ml ). Additionally, yeasts grown in glucose concentrations higher than 125 mM (P < 0.001) produced more exopolysaccharide than cells incubated in mannitol. For concentrations lower than 125 mM, no statistical difference was observed between the groups (P > 0.05; Fig. 1D ). Differences in kinetics of capsular and exopolysaccharide production further suggest that there is a differential regulation in the production of these two pools of PSs or they are generated by two different biosynthetic pathways.
Carbon source alters capsular thickness and surface distribution of antigen epitopes recognized by mAb 18B7
Chitin staining with Uvitex 3BSA and direct immunofluorescence with antibodies to GXM permitted relative measurements of capsular thickness and epitope distribution for mAb 18B7 ( Fig. 2A) . In all the conditions tested, mAb 18B7 bound to Cn cells in an annular fashion (Torres et al., 2005) . However, substantial differences in capsule thickness and epitope distribution were apparent between the different conditions tested. Cells grown in media containing Ն 125 mM mannitol displayed a thicker capsule, with diffuse capsular binding and fluorescence ( Fig. 2A) . Cells grown in Ն 250 mM glucose showed a smaller and well-defined outer ring, and less fluorescence distributed towards the cell body. At 125 mM glucose, the capsule was smaller and binding was more diffused. Smaller capsules were present at concentrations Յ 62.5 mM of both sugars and no substantial differences were observed. Additionally, cells cultivated in either sugar at these concentrations had a smaller, but very bright and dense compartment between the cell wall and the capsule.
When the number of epitopes recognized by 18B7 was compared with the volume of the capsule calculated from the cellular radius and cell body length, we observed that the distribution of epitopes on the cell surface was constant for cells grown in all mannitol concentrations, despite the differences in capsule size, and a Pearson correlation was observed (P = 0.0017, Pearson r = 0.88; Fig. 2B ). Lower mannitol concentrations induced a higher ratio of epitopes/ capsule volume. Additionally, yeasts grown in glucose had a much lower epitope/capsule volume ratio, which was nearly constant under the different concentrations used (Fig. 2C ). However, no correlation was observed between capsule size and GXM concentration in glucose medium (P = 0.68, Pearson r = -0.62).
When intensity of fluorescence was compared by fluorescence-activated cell sorting (FACS) in order to confirm the amount of capsular epitopes after labelling the capsule with FITC-conjugated mAb 18B7, yeasts grown in either mannitol or glucose showed a decrease in fluorescence intensity relative to cells grown in lower concentrations of carbon sources ( Fig. 2D and E, respectively, P < 0.05). When lower concentrations were used, despite the decrease in the fluorescence, the cell diameter also decreased considerably, as estimated from FSC-H values. Normalization of fluorescence intensity (FL1-H) by cell diameter inferred from FSC-H values resulted in a slight increase in the ratio, suggesting a higher density of epitopes for both carbon sources when cells were grown in concentrations lower that 62.5 mM ( Fig. 2F , P < 0.05). These results correlated with the immunofluorescence and ELISAs/cell volume ratio studies. Additionally, we also observed that Cn cells tended to aggregate at carbon concentrations < 62.5 mM, giving a higher FL1-H signal of each particle detected.
Carbon source influences capsule composition
As the capsules of Cn cells displayed differences in volume and epitope distribution, we sought to determine whether different carbon sources could alter the capsular chemical composition. For instance, metabolic changes could alter the expression of biosyntethic enzymes or production of the PSs precursors, resulting in a different capsular structure and composition. Zeta potential measurements indicate the charges surrounding a cell surface and our measurements demonstrated that the carbon source impacted cell charge (Fig. 3A) . At concentrations between 500 and 3.9 mM, cell charge measurements were similar for cells grown with either sugar. Cell charge increased in magnitude at lower concentrations in a similar manner for both sugars. In contrast, cells grown in media containing 1000 mM mannitol manifested increased negative charge whereas 1000 mM glucose induced a significant reduction in the negative charge. Notably, the trend in both curves was very similar to the curve of 18B7 binding detected on the cell capsule under each condition (mannitol, P = 0.07, Pearson r = 0.64 and glucose, P = 0.03, Pearson r = 0.71) (Fig. 1C) . This suggests that cell charge is directly proportional to the amount of epitopes on the capsule of Cn yeast cells for either carbon source used.
In order to characterize the sugar composition of the Cn capsule, we measured the ratios of each component monosaccharides. We observed that PS from cells grown in glucose contained more mannose residues compared with cells grown in mannitol (P < 0.001). However, glucose was shown to be more frequent in capsules of Cn yeasts grown in mannitol (P < 0.001). These effects were less pronounced when the carbon source concentrations were below 62.5 mM. The average molar ratios of cells grown in either glucose or mannitol are shown in Fig. 3B . Except for the cells grown in 500 mM of mannitol, where glucose was the major component, the general order of molar composition was mannose, followed by xylose and glucose for both carbon sources. Slight increases in the amount of glucuronic acid residues in PS from cells grown in either sugar accounted for the decreasing of the Zeta potential as described previously (Nosanchuk and Casadevall, 1997; Frases et al., 2008) . 
Carbon source affects the formation of capsular PS fibres
To analyse the structure of the capsular PS at the molecular level, we used dynamic light scattering to provide some information about size distribution and frequency of the fibres forming the PS (Fig. 4) . When mannitol was used as carbon source, the largest PS fibres were observed at 125 mM, followed by 62.5, 250 and 500 mM, correlating with the light microscopy data for capsule size. A linear correlation was obtained using the average of capsule diameter calculated by India ink measurements versus the diameter of PS fragments (R 2 = 0.77; P < 0.05; Fig. 4C ). Interestingly, when the mannitol concentration was diminished, two or more dominant populations were observed in the capsule of Cn yeasts. Cells cultivated in glucose had a different pattern of PS fibre production. The largest fibres were observed when yeasts were grown in 62.5 mM of glucose, followed by 250, 500 and 125 mM.
These findings corresponds with the largest capsule size for this group as measured by light microscopy, and an additional correlation was obtained between capsule diameter and diameter of PS fragments (R 2 = 0.71; P < 0.05, Fig. 4C ).
In vivo supplementation with carbohydrates impacts the pathogenesis of cryptococcosis
We tested whether the in vivo administration of either glucose or mannitol would alter the pathogenesis of cryptococcosis. In our model, mice given PBS, glucose or mannitol had similar pulmonary colony-forming units (cfu) (Fig. 5A, 4 ; P < 0.05) or glucose-treated animals (5.20 ¥ 10 3 yeasts g -1
; P < 0.05). 
Histological analysis
Histological examination revealed differences in cellular responses in the lungs of mannitol-or glucose-treated and control animals. The lungs of the infected animals exhibited foci of inflammatory reaction, granulomatous inflammation composed of macrophages and epithelioid cells, surrounded by perivascular lymphocytes and neutrophils ( Fig. 5C-E) . A large collection of extracellular Cn yeast cells could also be observed in the alveolar, perivascular spaces and parenchyma, as well as some intracellular yeast trapped in the interior of numerous granulomas. Notably, a greater numbers of extracellular yeasts were present in the lung parenchyma of mannitol-(45.9 Ϯ 15.6%, P < 0.05) and glucose-(25.5 Ϯ 4.7%, P < 0.05) treated animals compared with controls (11.7 Ϯ 7.1%).
Cn cells show differential capsule/cell body ratio in vivo depending on carbon sources
Organ homogenates of infected mice were visualized by direct immunofluorescence with antibody to GXM to identify Cn yeast cells in vivo. Cn from lung homogenates displayed thicker capsules compared with yeast cells identified in suspensions from brain ( Fig. 6A and B, respectively). Although there were fewer yeast cells, there were no differences in cell or capsule size in the fungi isolated from the brain after glucose or mannitol treatment. However, when mannitol was administered, a substantial increase was observed in capsule of yeasts in the lung tissues, despite the smaller cell body diameter, which then increased the capsule volume/cell body volume ratio (8.62; P < 0.05; Fig. 6C and E). Glucose and control groups had similar values for capsule volume/cell body volume ratio of yeast isolated from lungs (3.92 and 4.50, respectively; Fig. 6B and D) . This also corroborates the previous result showing the difference in capsule volume as observed in vitro.
GXM production is regulated by presence of mannitol in vivo
The amount of soluble GXM was measured in different tissues and serum of mice challenged with Cn in the presence or absence of mannitol and glucose. GXM levels in lung and serum positively correlated with host fungal burden. There was a trend to a higher GXM levels in serum of mannitol-treated mice (0.48 Ϯ 0.37 mg ml ) and control animals (0.070 Ϯ 0.037 mg ml ), but this differ- ence was not statistically significant (data not shown). We also evaluated the distribution of GXM in lung and brains of infected animals. In the lungs, the highest GXM values were obtained in organ homogenates of animals treated with mannitol (74.73 Ϯ 17.7 mg ml ) and control groups (26.90 Ϯ 11.4 mg ml -1 ) (Fig. 7A) ; however, glucose and control groups were statistically similar In contrast, the GXM levels in brains of infected control animals were significantly higher than in mice from the mannitol and glucose groups (0.43 Ϯ 0.40 vs. 0.017 Ϯ 0.012 and 0.019 Ϯ 0.005 mg ml -1 , respectively; P < 0.05, Fig. 7B ), and the GXM levels correlated with the brain cfu.
Discussion
This study began when we attempted to use mannitol to osmotically stabilize extracellular vesicle formation (Sethi and Maeda, 1983; van Rooijen and van Nieuwmegen, 1984; van Rooijen et al., 2003) in cryptococcal cultures and improve the yield of vesicles and serendipitously observed that supplementation of media with mannitol had a tremendous effect on capsule size. The physiological significance of mannitol secretion by Cn in its native milieu and in vivo is still unclear. Cn produces D-mannitol in vitro and in vivo. D-mannitol has been identified in cerebral and pulmonary cryptococcomas (Himmelreich et al., 2003; Dzendrowskyj et al., 2005) , and D-mannitol has been characterized as a quantitative marker for experimental cryptococcal meningitis (Wong et al., 1990) . However, concentrations of mannitol in the microenvironment of cerebral and pulmonary cryptococcomas have not been determined, and might be much higher than the maximum value reported for CSF and serum (50 mM) (Megson et al., 1996; Garcia-morales et al., 2004) . Yeast polyol metabolism through mannitol has been considered as a potential biochemical pathway for virulence , as a non-mannitol-producing mutant strain of Cn was about two orders of magnitude less virulent than its parental strain (Wong et al., 1990) . Despite the wellcharacterized D-mannitol secretion and its correlation to the degree of virulence, the effects of D-mannitol on capsule production of Cn have not been explored. Cn yeasts can use mannitol as the sole carbon source and incorporate this sugar intact to the capsule, as the carbon chain of mannitol is not altered by the yeast (Cherniak et al., 1998a) .
To evaluate these effects, we investigated the modulation of capsular growth in vitro and the outcome of infected mice in the presence of mannitol and glucose. The in vitro experiments demonstrated that mannitol induced a thicker capsule of Cn cells when added to cryptococcal cultures in the range within 500 and 7.81 mM. The highest difference was observed when concentrations of 125 mM of both sugars were used, resulting in mannitol grown cells with capsule volumes 10 times larger than glucose grown cells. When we evaluated the amount of PSs using an ELISA, mannitol grown cells had greater reactivity in the capsule, about four times higher when compared with glucose grown cells. However, higher amounts of epitopes recognized by this antibody were observed only in mannitol concentrations of 125 and 62.5 mM. Yeasts grown in glucose were able to produce and secrete more PS than yeasts grown in mannitol at concentrations higher than 125 mM. These results, along with the capsular volume, show a different regulation in terms of capsular and exopolysaccharide production dependent on concentration and carbon sources used. Furthermore, as we observed that higher exopolysaccharide productions did not always correlate with higher capsular PS production, capsular and exopolysaccharide could yet constitute different biosynthetic products from different PS pathway production.
Different physical chemical properties impact binding of antibody to GXM. The reactivity of these PSs with the 18B7 antibody was additionally evaluated by FACS; and these data were correlated with cell size. A better reactivity was observed for cells with smaller capsules, when the fluorescence intensity was normalized by cell size, suggesting that structural differences in the capsular PSs could result in antigenic differences (Charlier et al., 2005; Frases et al., 2008) .
To characterize possible capsular structural differences, we measured Zeta potential and analysed the glycosyl composition of capsular PSs extracted from the yeasts. Although the concentrations of sugars altered cell charge, values were similar between the carbon sources used when a similar concentration was considered, except at 1000 mM where mannitol increased the negative cell charge and glucose reduced the negative charge. In all the samples tested, mole percentage of mannose was higher than the mole percentage of xylose. GXM from H99 strain of Cn in chemically defined liquid medium is expected to display the PS motif M2 (mannose 3-glucuronic acid-xylose2) (Cherniak et al., 1991; 1998b) . However, we observed that the concentration and carbon source impacted the sugar concentration and thus, as the molar ratio of the PSs differed, other reported motifs could be produced (for example, M5). Further characterization of PS fractions obtained from these cells by light scattering demonstrated significant structural differences. For instance, cells grown in 125 mM mannitol produced the largest PS fibres, which correlated with the largest India ink exclusion zone. With the other concentrations evaluated, capsular fibres of glucose grown yeasts were always larger than mannitol grown yeasts. However, as the capsule thickness for cells grown in mannitol was much larger, the shorter PS fibres must associate with either different branching formations or aggregate -via cationic bridges -to form a thicker capsule. Furthermore, as the fluorescence intensity was similar for cells with a larger capsule compared with cells with a smaller capsule, epitope accessibility and exposure is impacted by the carbohydrate substrate and concentration.
It is unclear whether the effects of mannitol on capsule induction are due to alterations in metabolic pressure, with incorporation of the intact sugar into the capsule, or if this simple carbohydrate works as a quorum sensing molecule, as it is produced by the fungus during its growth (Molloy, 2006) . In vivo, the role of mannitol as a metabolic product remains unclear. However, we created a mouse model by administering therapeutic doses (based on dosages used clinically) and compared with glucose. Mannitol treatment resulted in a reduction in the dissemination of Cn to the brain. These results are consistent with the findings that Cn mutants that cannot downregulate their capsule have impaired phagocytosis and extrapulmonary dissemination and (Casadevall and Perfect, 1998; Shea et al., 2006) . Animals receiving glucose also had a reduction in dissemination, although their capsules in the lung were not significantly larger than Cn isolated from controls. However, in this situation a different explanation may be operative. Systemic glucose administration could have induced a transient diabetic state in mice that increased susceptibility to infection, given that hyperglycaemia causes macrophage dysfunction and caused inhibition of tumour necrosis factor production (Satomi et al., 1985; Kawakami et al., 1996; Liu et al., 1999) , which in turn could have reduced dissemination in macrophages.
Tissue GXM levels correlated with the cfu determinations and the capsular size of the yeast in the respective tissues. Although GXM can be cleared from serum over several days (Lendvai et al., 1998) , deposition in organs and the presence of GXM in serum has diverse adverse effects on immune cell function (Retini et al., 1996) , including downregulation of T-cell responses (Vecchiarelli, 2007) , inhibition of neutrophil chemotaxis (Dong and Murphy, 1996; Monari et al., 2002) and impared macrophage killing (Monari et al., 2003) .
Mannitol is clinically utilized as a hyperosmolar agent for the treatment of intracranial hypertension (ICP) and as a diuretic and anti-hypertensive (Sakowitz et al., 2007) . This polyol prevents visual loss and other neurological sequelae because of high ICP (Bhardwaj, 2007) , by setting up an osmotic gradient across the blood-brain barrier (osmotherapy) reducing CSF pressure. D-mannitol is also present in the CSF of patients with cryptococcal meningitis, and this produced sugar competes with intravenous D-mannitol osmotherapy because of its inability to cross the blood brain barrier, increasing the CSF pressure and leading to oedema formation. Hence, secretion of D-mannitol by Cn may contribute to cerebral oedema. Secretion may also increase the microbe's tolerance of heat and osmotic stresses and interfere with phagocytic killing by scavenging reactive oxygen species, resulting in an enhancement in Cn pathogenicity (Chaturvedi et al., 1996a,b) .
High mannitol concentrations in CSF has been also positively correlated with high titres of cryptococcal antigen (Wong et al., 1990) and high intracranial pressure (Megson et al., 1996; Liappis et al., 2008) . Pathogenesis of raised ICP tends to occur in patients with prolonged disease, and this prognosis is strongly correlated with high cryptococcal antigen titres (Saag et al., 2000) . The possible mechanism of increased CSF osmolality is related to the production of high-molecularweight cryptococcal PS, induced by the accumulation of mannitol, and also the presence of a large burden of yeasts plugging the arachnoid villi, reducing the outflow gradient of CSF. Mannitol that has crossed the bloodbrain barrier, and the mannitol produced by the fungus may draw fluid into the central nervous system, aggravating then the vasogenic oedema. Other serious effects are permanent neurological sequelae such as reduced visual acuity, blindness, papilloedema and deafness. Our results have clinical implications as mannitol has been administered during severe cases of cryptococcosis for the treatment of increased ICP, but this medical intervention has not been effective (Saag et al., 2000) . This study showing the regulatory role of mannitol on capsule biosynthesis and Cn virulence further suggests that mannitol therapy is relatively contraindicated for cryptococcosis.
Experimental procedures
Fungal cultures
Cryptococcus neoformans ATCC H99 was grown in chemically defined medium composed of MgSO4 (10 mM), KH2PO4 (29.4 mM), glycine (13 mM) and thiamine-HCl (3 mM), pH 5.5 and supplemented with 1000, 500, 250, 125, 62.5, 31.25, 15.6, 7.8 and 3 .9 mM of either glucose or mannitol as carbon sources. For all experiments, Cn were cultivated for 2 days at 30°C with rotary shaking. Growth in different conditions was evaluated in cultures starting with 10 6 yeasts ml -1 , and growth curves were obtained photometrically (Bioscreen C, Growth Curves USA, NJ, USA). Cell density after 48 h of growth was confirmed using a haematocytometer.
Light microcopy and India ink staining
Samples were prepared from each condition by dilutions in PBS according to haemocytometer counts. An aliquot of each Cn culture was mixed with a drop of India ink (BD Biosciences, NJ, USA) and examined using an Axiovert 200 M inverted microscope (Carl Zeiss Micro Imaging, NY). Images were collected with a 40¥ lens and photographed with an AxiocamMR camera controlled by AxioVision 4.4 software. Capsule size was measured in ImageJ 1.39g software (National Institutes of Health, NIH, Bethesda, MD) as the distance between capsule border and the cell wall, corresponding to the India ink exclusion zone. At least 100 Cn yeasts were measured for each growth condition.
GXM ELISA
An inhibition ELISA was developed for the detection of capsular and exopolysaccharides from cultures on different growth conditions. Initially, a 96-well polystyrene plate (NUNC) (reaction plate) was coated with 50 ml of a 10 mg ml -1 purified GXM diluted in PBS and incubated overnight at 4°C. Reaction plates were washed three times with TBS-T (10 mM Tris-HCl, 150 mM NaCl, 1 mM NaN3, 0.1% Tween 20, pH 7.4) and blocked with 200 ml of blocking solution [2% (w/v) bovine serum albumin in TBS-T] for 1 h at 37°C. A second polystyrene 96-round-well microtitre plate (Nunc A/S, Kamstrup, Denmark) (inhibition plate) was also blocked for 1 h at 37°C with the same blocking buffer. After blocking the ELISA plates were washed with PBS. A standard GXM curve with concentrations ranging from 10 to 0.0565 mg ml -1 (obtained by 1:3 serial dilutions) was constructed, and 50 ml of each concentration was added to the inhibition plate in duplicate. To measure the capsular PS, 10 5 washed Cn yeasts from each condition were added to the wells in duplicate. To measure the extracellular PS, the supernatant samples were diluted 1:10 and 50 ml were added to the wells in duplicate. Cn cells and extracellular PS samples were diluted across the plate. Fifty microlitres of a 4 mg ml -1 solution of the mAb to GXM 18B7 was added to all wells on the inhibition plate and then incubated for 2 h at 37°C. The content of the inhibition plate was then transferred to the respective wells in the reaction plate. The excess of antibody to GXM was allowed to interact with GXM adsorbed to the reactive plate for 1 h at 37°C. Plate wells were then washed three times and coated with 50 ml of a 1:1500 dilution of alkaline phosphatase-conjugated goat anti-mouse immunoglobulin G1 (IgG1) (Southern Biotechnology) in blocking buffer and incubated for 1 h at 37°C. Plates were then washed and incubated with 50 ml well -1 of 1 mg ml 
Immunofluorescence with antibody to capsule
Aliquots from each growth condition containing 5 ¥ 10 6 Cn yeasts were transferred to microcentrifuge tubes. Cells were quickly spun down to remove excess of liquid and suspended in 100 ml of a 100 mg ml -1 solution of 18B7 mAb in blocking solution. Tubes were incubated in an orbital shaker for 1 h at 37°C. Cells were washed three times with TBS-T by centrifugation. The pellets were then suspended in 100 ml of a 1:100 dilution in blocking solution of a FITC-conjugated goat anti-mouse IgG1 (Southern Biotechnology). Tubes were incubated for 1 h at 37°C and then washed with TBS-T. Pellets were suspended in mounting solution (Biomeda Corp, Foster City, CA) and the suspension applied to a microscopy slide. Cells were examined with an Olympus AX70 fluorescence microscope using a 495 nm filter, with a magnificence of 40¥.
Fluorescence-activated cell sorting
Cryptococcus neoformans (10 6 ) were transferred to a microcentrifuge tube and incubated for 1 h at 37°C with 10 mg ml -1 of a FITC-conjugated mAb 18B7 diluted in PBS. Yeasts were washed, and the fluorescence intensity of cells analysed in a FACScan Flow Cytometer (BD Biosciences, Franklin Lakes, NJ). A forward side scatter (FSC) versus fluorescence (FL1) graphs was plotted.
Zeta potential measurements
A total of 10 5 yeast cells were washed three times with MilliQ water and suspended in pure distilled lipopolysaccharide-free water. Zeta potential (z), particle mobility and shift frequency were analysed comparing the different zeta potentials on cells from growth in different carbon sources. These measurements were calculated in a Zeta potential analyser (ZetaPlus, Brookhaven Instruments Corp., Holtsville, NY). z is a measurement of charge (in mV) defined as the potential gradient that develops across the interface between a boundary liquid in contact with a solid and the mobile diffuse layer in the body of the liquid. It is derived from the equation z = (4phm)/D, where D is the dielectric constant of the medium, h is the viscosity, and m is the electrophoretic mobility of the particle.
Light scattering and particle sizes of capsular PSs
Capsular PS was isolated as described (Frases et al., 2009) . Yeast cells were washed three times in water, suspended in five-cell pellet volumes of dimethylsulfoxide and incubated at room temperature for 30 min. This procedure was done twice, and the fractions were pooled. Cells were centrifuged for 1100 g for 10 min and supernatant collected. This fraction was then dialysed against distilled water for 12 h, with water changes for at least six times. These capsular PS preparations were analysed by QELS in a 90Plus/BI-MAS Multi Angle Particle Sizing analyser (Brookhaven Instruments) and the effective diameter and polydispersity measured. Effective diameter is considered the diameter of the imaginary coaxial cylinder that intersects the surface of the thread. Polydispersity is a measure of the distribution of molecular mass in a complex mixture of polymers and indicates the distribution of individual molecular masses.
Glycosyl composition of extracted capsular PSs
Extracted capsular PS preparations were lyophilized, and PS fractions were dissolved in methanol/1M HCl and incubated at 80°C for 18 h. Methanolysed samples were then per-Otrimethylsilylated by treatment with Tri-Sil (Pierce) for 30 min at 80°C. The per-O-TMS derivatives were analysed by gas chromatography coupled to mass spectrometry (GC-MS). The derivatized structures were first separated on an HP 5890 gas chromatograph using a Supelco DB-1 fused silica capillary column (30 m ¥ 0.25 mm ID). Peaks detected by GC were fragmented in a 5970 MSD mass spectrometer, interfaced to the gas chromatograph. Carbohydrate standards included arabinose, rhamnose, fucose, xylose, glucuronic acid, galacturonic acid, mannose, galactose, glucose, mannitol, dulcitol and sorbitol. The percentage of each element was measured as a function of thermal conductivity. Elemental ratios were calculated by dividing the percentage of each element measured in the sample by its respective atomic weight. The values reported are from two independent analysis using different sample batches.
In vivo model
Animal procedures were approved by the Institute for Animal Studies of the Albert Einstein College of Medicine. Four to six week BALB/c mice (National Cancer Institute) received 100 ml of intraperitoneal injections of a 20% (w/v) solution of glucose or mannitol every 8 h for 12 consecutive days. Glucose or mannitol was administered intraperitoneally in a dose corresponding to the in vivo administration of mannitol used for the management of increased intracranial pressure (approximately 1.5 g kg -1 ) (Rudehill et al., 1993; Silva et al., 2009; Singhi and Tiwari, 2009) . Control mice received PBS. At day 7 of treatment, mice were infected intratracheally with 10 7 yeast cells. At day 12, the mice were killed, brains and lungs were immediately removed, and sections of each organ were fixed in a formalin solution and stained with H&E for histology. Slides were observed with an Olympus AX70 microscope using a bright field, with a magnificence of 20¥.
The remaining excised brain and lung tissues were weighed and then homogenized using 70 mm cell strainers (BD Biosciences, NJ, USA) in PBS buffer. Organ homogenates were serially diluted and plated in duplicates on Sabouraud Dextrose Agar plates (Difco Laboratories). After 2 days of incubation at 30°C, the number of colonies was enumerated. Capsule dimensions in organ homogenates was also measured by mixing an aliquot of the lung or brain homogenates with India ink. Coverslips were applied and the slides and the cells observed as described. Additionally, immunofluorescence with the mAb 18B7 using brain and lung homogenates was performed. Briefly, 100 ml of brain or lung homogenate was placed on a slide microcentrifuge tube and immunofluorescence done as described above. Twenty microlitres of 1% Uvitex 3BSA-PBS (Ciba-Geigy, Greensboro, NC) were added to the samples and incubated for 10 min. Uvitex 3BSA binds chitin in the yeast cell wall and was used to delineate the cell wall. Samples were visualized by immunofluorescence microscopy as described.
Finally, an inhibition ELISA to detect GXM in organ supernatants was performed as above, with GXM standard curve ranging from 2 mg ml -1 to 0.98 ng ml -1 , with 0.25 mg ml -1 of mAb 18B7.
Statistical analyses
All statistical analyses were performed using GraphPad Prism version 5.00 for Windows (GraphPad Software, San Diego, CA, USA). A one-way ANOVA using a Kruskall-Wallis non-parametrical test was used to statistically compare the differences among groups, and an individual comparison between groups was done by Bonferoni post test. A 95% confidence interval was considered in all experiments.
